APA
Muranova, A., Kovalev, D. & Patel, C. (2023). First Dose Pembrolizumab-induced Toxicity in Patient Treated for Malignant Thymoma: Overlap Syndrome of Myasthenia Gravis, Myositis and Myocarditis. IAR Journal of Medical Case Reports, 4(1), None-None.
MLA
Muranova, Alexandra, Dmitri Kovalev and Chilvana Patel. "First Dose Pembrolizumab-induced Toxicity in Patient Treated for Malignant Thymoma: Overlap Syndrome of Myasthenia Gravis, Myositis and Myocarditis." IAR Journal of Medical Case Reports 4.1 (2023): None-None.
Chicago
Muranova, Alexandra, Dmitri Kovalev and Chilvana Patel. "First Dose Pembrolizumab-induced Toxicity in Patient Treated for Malignant Thymoma: Overlap Syndrome of Myasthenia Gravis, Myositis and Myocarditis." IAR Journal of Medical Case Reports 4, no. 1 (2023): None-None.
Harvard
Muranova, A., Kovalev, D. and Patel, C. (2023) 'First Dose Pembrolizumab-induced Toxicity in Patient Treated for Malignant Thymoma: Overlap Syndrome of Myasthenia Gravis, Myositis and Myocarditis' IAR Journal of Medical Case Reports 4(1), pp. None-None.
Vancouver
Muranova A, Kovalev D, Patel C. First Dose Pembrolizumab-induced Toxicity in Patient Treated for Malignant Thymoma: Overlap Syndrome of Myasthenia Gravis, Myositis and Myocarditis. IAR Journal of Medical Case Reports. 2023 Jan;4(1):None-None.
Download PDF
Download XML
